Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $18.70 billion. The enterprise value is $19.24 billion.
Important Dates
The next estimated earnings date is Thursday, February 20, 2025, after market close.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.14 million shares outstanding. The number of shares has increased by 8.42% in one year.
| Current Share Class | 70.14M |
| Shares Outstanding | 70.14M |
| Shares Change (YoY) | +8.42% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 102.91% |
| Float | 69.79M |
Valuation Ratios
The trailing PE ratio is 46.48 and the forward PE ratio is 72.35. Insulet's PEG ratio is 2.49.
| PE Ratio | 46.48 |
| Forward PE | 72.35 |
| PS Ratio | 9.41 |
| Forward PS | 7.86 |
| PB Ratio | 16.72 |
| P/TBV Ratio | 19.34 |
| P/FCF Ratio | 82.30 |
| P/OCF Ratio | 57.04 |
| PEG Ratio | 2.49 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 45.36, with an EV/FCF ratio of 84.67.
| EV / Earnings | 45.70 |
| EV / Sales | 9.70 |
| EV / EBITDA | 45.36 |
| EV / EBIT | 55.60 |
| EV / FCF | 84.67 |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 1.29.
| Current Ratio | 3.68 |
| Quick Ratio | 2.53 |
| Debt / Equity | 1.29 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 6.34 |
| Interest Coverage | 8.50 |
Financial Efficiency
Return on equity (ROE) is 48.79% and return on invested capital (ROIC) is 9.36%.
| Return on Equity (ROE) | 48.79% |
| Return on Assets (ROA) | 7.87% |
| Return on Capital (ROIC) | 9.36% |
| Revenue Per Employee | $661,300 |
| Profits Per Employee | $140,300 |
| Employee Count | 3,000 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | -124.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.21% in the last 52 weeks. The beta is 1.22, so Insulet's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +24.21% |
| 50-Day Moving Average | 253.78 |
| 200-Day Moving Average | 207.97 |
| Relative Strength Index (RSI) | 54.85 |
| Average Volume (20 Days) | 607,453 |
Short Selling Information
The latest short interest is 3.05 million, so 4.35% of the outstanding shares have been sold short.
| Short Interest | 3.05M |
| Short Previous Month | 3.01M |
| Short % of Shares Out | 4.35% |
| Short % of Float | 4.37% |
| Short Ratio (days to cover) | 4.96 |
Income Statement
In the last 12 months, Insulet had revenue of $1.98 billion and earned $420.90 million in profits. Earnings per share was $5.74.
| Revenue | 1.98B |
| Gross Profit | 1.39B |
| Operating Income | 346.00M |
| Pretax Income | 267.50M |
| Net Income | 420.90M |
| EBITDA | 424.10M |
| EBIT | 346.00M |
| Earnings Per Share (EPS) | $5.74 |
Full Income StatementBalance Sheet
The company has $902.60 million in cash and $1.44 billion in debt, giving a net cash position of -$538.60 million or -$7.68 per share.
| Cash & Cash Equivalents | 902.60M |
| Total Debt | 1.44B |
| Net Cash | -538.60M |
| Net Cash Per Share | -$7.68 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 15.94 |
| Working Capital | 1.35B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $327.80 million and capital expenditures -$100.60 million, giving a free cash flow of $227.20 million.
| Operating Cash Flow | 327.80M |
| Capital Expenditures | -100.60M |
| Free Cash Flow | 227.20M |
| FCF Per Share | $3.24 |
Full Cash Flow StatementMargins
Gross margin is 70.00%, with operating and profit margins of 17.44% and 21.22%.
| Gross Margin | 70.00% |
| Operating Margin | 17.44% |
| Pretax Margin | 14.96% |
| Profit Margin | 21.22% |
| EBITDA Margin | 21.38% |
| EBIT Margin | 17.44% |
| FCF Margin | 11.45% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.42% |
| Shareholder Yield | -8.42% |
| Earnings Yield | 2.25% |
| FCF Yield | 1.22% |
Dividend DetailsAnalyst Forecast
The average price target for Insulet is $265.81, which is -0.29% lower than the current price. The consensus rating is "Buy".
| Price Target | $265.81 |
| Price Target Difference | -0.29% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 15.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 5.63 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.63 |
| Piotroski F-Score | 7 |